Pauls Aldi??
(1971?2020) bija latvie?u
?rsts
infektologs
, hepatologs un augstskolas doc?t?js, miris p?c infic??an?s ar
SARS-CoV-2 v?rusu
COVID-19 pand?mijas
laik?.
[1]
Dzimis 1971. gada 8. apr?l? R?g? akad?misk?s air??anas trenera un ?rstes ?imen?.
M?c?j?s
R?gas 64. vidusskol?
(1978?1989), stud?ja
Latvijas Medic?nas akad?mijas
(AML) ?rstniec?bas fakult?t? (1989?1995), tad kl?niskaj? rezident?r? infektolo?ijas specialit?t? (1995?1998). 1989. gad? vi?u uz??ma
akad?miskaj? vien?b? "Austrums"
, bija t?s vecbiedrs.
[2]
Str?d?ja
Latvijas Infektolo?ijas centr?
par
HIV/AIDS
noda?as vad?t?ju, kop? 2009. gada par
Paula Stradi?a Kl?nisk?s universit?tes slimn?cas
(PSKUS) Infekciju slim?bu ?rst??anas un hospit?l?s epidemiolo?ijas konsultat?v? dienesta ?rstu. No 2015. gada bija
R?gas Stradi?a universit?tes
(RSU) Infektolo?ijas katedras lektors.
[3]
Pauls Aldi?? bija viens no
HIV
, im?nsupres?to pacientu un v?rusa hepat?ta modern?s ?rst??anas pamatlic?jiem Latvij?.
Miris 2020. gada 31. decembr? no
COVID-19
izrais?t?m komplik?cij?m.
[4]
Izvad?ts no
R?gas Sv?t? P?vila eva???liski luterisk?s bazn?cas
, apbed?ts R?gas I Me?a kapos.
- Aldi??, Pauls. Aknu patolo?ija pacientiem, kas lieto biolo?iskos medikamentus. Latvijas ?rsts Nr. 2 (2016), 36.-38.lpp.
- Stepens A, Groma V, Skuja S, Platk?jis A, Aldi?? P, Ek?teina I, M?rti?sone I, Bricis R, Donaghy M. The outcome of the movement disorder in methcathinone abusers: clinical, MRI and manganesemia changes, and neuropathology. European Journal of Neurology 2014; 21(2), 199-205
- Stepens A, Logina I, Liguts V, Aldins P, Eksteina I, Platk?jis A, M?rtinsone I, T?rauds E, Rozent?le B, Donaghy M. A Parkinsonian syndrome in methcathinone users and the role of manganese. N Engl J Med. 2008;358(10):1009-1017
- Kolupajeva T, Aldins P, Guseva L, Dusacka D, Sondore V, Viksna L, Rozentale B. HIV drug resistance tendencies in Latvia. Cent Eur J Public Health. 2008;16(3):138-140
- Peters L, Mocroft A, Soriano V, Rockstroh JK, Losso M, Valerio L, Aldins P, Reiss P, Ledergerber B, Lundgren JD. EuroSIDA Study Group. Hepatitis C virus coinfection does not influence the CD4 cell recovery in HIV-1-infected patients with maximum virologic suppression. J Acquir Immune Defic Syndr. 2009;50(5):457-463
- Mocroft A, Horban A, Clotet B, d'Arminio Monforte A, Bogner JR, Aldins P, Staub T, Antunes F, Katlama C, Lundgren JD. EuroSIDA Study Group. Regional differences in the risk of triple class failure in European patients starting combination antiretroviral therapy after 1 January 1999. HIV Med. 2008;9(1):41-46
- Podlekareva D, Mocroft A, Kirk O, Reiss P, Aldins P, Katlama C, Kovari H, Stellbrink HJ, D'Arminio Monforte A, Lundgren JD. Eurosida Study Group. Fungal infection as a risk factor for HIV disease progression among patients with a CD4 count above 200/microl in the era of cART. Scand J Infect Dis. 2008;40(11?12):908-913
- Mocroft A, Kirk O, Aldins P, Chies A, Blaxhult A, Chentsova N, Vetter N, Dabis F, Gatell J, Lundgren JD. EuroSIDA study group. Loss to follow-up in an international, multicentre observational study. HIV Med. 2008;9(5):261-269.
[5]
